Legal Representation
Attorney
Anna Kurian Shaw
USPTO Deadlines
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 10, 2021 | ABN1 | O | ABANDONMENT - EXPRESS MAILED | Loading... |
| May 10, 2021 | MAB1 | E | ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT | Loading... |
| May 7, 2021 | EXAR | I | TEAS EXPRESS ABANDONMENT RECEIVED | Loading... |
| Feb 1, 2021 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Feb 1, 2021 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Feb 1, 2021 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Dec 21, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 21, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 21, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 14, 2020 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Aug 14, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Aug 14, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Aug 14, 2020 | EWOR | I | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | Loading... |
| Aug 14, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Aug 14, 2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jun 24, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 24, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 24, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 21, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 7, 2020 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Apr 6, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 3, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of gastrointestinal diseases, cardiovascular diseases, pain treatment, anti-infectious diseases, respiratory diseases, diabetes, allergic reactions, Meniere's diseases, diseases associated with the immune system; pharmaceutical preparations for the treatment of gynecological and obstetrical diseases and conditions; pharmaceutical preparations for the treatment of hematological and oncological diseases and conditions
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the wording "NORDIC" in black followed by a vertical green rectangle.
Color Claim
The color(s) black and green is/are claimed as a feature of the mark.
Classification
International Classes
005